Century Therapeutics, Inc.

NASDAQ:IPSC

1.7 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -31.207-28.062-39.398-32.72-33.291-31.264-31.682-30.749-30.988-37.513-28.194-26.009-23.273-18.348-15.531-13.07-15.301-9.673
Depreciation & Amortization 3.4623.2263.5523.353.2342.9082.8382.7741.6681.161.0511.0440.9350.7180.510.410.2820.2
Deferred Income Tax 00-13.55304.22000000000004.7220
Stock Based Compensation 3.5033.2073.5623.9783.2853.7972.7322.7862.7712.381.6361.221.7110.0950.3740.1440.1370.221
Change In Working Capital 0.713-9.046-2.91112.184.089-3.9782.5910.4120.48120.4620.826-0.5231.849-4.9491.2173.167-1.8312.309
Accounts Receivables 000000000000000000
Change In Inventory 000000000000000000
Change In Accounts Payables -1.8780.689-2.8873.994-0.514-2.954-1.6330.706-2.358-1.5032.292-0.5781.376-4.938-0.341.605-0.831.627
Other Working Capital 2.591-9.735-0.0248.1864.603-1.0244.224-0.2942.838121.965-1.4660.0550.473-0.0111.5571.562-1.0010.682
Other Non Cash Items 8.5029.39722.518-0.437-0.787-0.6820.6140.5380.5140.2640.330.2850.2890.3050.210.1240.0510.059
Operating Cash Flow -27.332-30.248-26.23-13.649-19.25-29.219-22.907-24.239-25.55586.753-24.351-23.983-18.489-22.179-13.22-9.225-11.94-6.884
Investing Activities:
Investments In Property Plant And Equipment -0.265-0.539-0.98-3.265-4.5-4.991-6.268-9.812-10.457-4.067-16.721-15.736-10.629-1.884-1.904-4.506-0.716-2.699
Acquisitions Net -9.608092.148-7.482-11.474-73.192-238.218-32.476-22.975-55.227-30.33600000-4.7220
Purchases Of Investments -53.86-35.087-9.692-57.499-99.014-42.829-50.337-66.382-34.221-103.06-41.888-146.077-17.219-124.85-36.927-8.518-2.936-1.479
Sales Maturities Of Investments 29.86947.16729.27564.981110.48879.15852.33298.85857.19663.0938.00714.75916.27.718.0513.510.10
Other Investing Activites 012.0819.5837.48211.47473.192238.21832.47622.97555.22730.336-131.318-1.019-117.15-18.8774.982-4.722-1.479
Investing Cash Flow -33.86411.54118.6034.2176.97431.338-4.27322.66412.518-44.037-20.602-147.054-11.648-119.034-20.7810.4761.726-4.178
Financing Activities:
Debt Repayment 00-10.2410-10.2410000000000000
Common Stock Issued 56.6970.366-0.3560.30.1240.4480.0950.1380.04726.8780.083-0.467221.9520.0470000
Common Stock Repurchased 00-0.35600000000-0.466000000
Dividends Paid 000000000000000000
Other Financing Activities 017.82910.2410.3-10.1170.4480.0950.1380.04826.8780.0230.0012.697193.43838.19.601-0.0110
Financing Cash Flow 56.69718.195-0.3560.3-10.1170.4480.0950.1380.04726.8780.106-0.466224.649193.48538.19.601-0.0110
Other Information:
Effect Of Forex Changes On Cash 000000000000000000
Net Change In Cash -5.355-0.512-7.983-9.132-22.3932.567-27.085-1.437-12.9969.594-44.847-171.503194.51252.2724.0990.852-10.225-11.062
Cash At End Of Period 41.45746.81247.32457.28666.41888.81186.244113.329114.766127.75658.162103.009274.5128027.72823.62922.77733.002